Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, October 30, 2026

Back to today

From X

@ChrisCamillo 3 clicks

Chris Camillo on X

One of the most important disciplines in investing is constantly updating the best argument against your own position. Not dismissing it. Not looking for reasons it’s wrong. Actually understanding it well enough to decide how much conviction your own thesis deserves. $AMZN has badly lagged the market and many other AI names recently, and I think the counter thesis has evolved. The biggest new threat is agentic commerce. Meta’s Muse and other AI agents could increasingly control product discovery and purchasing, potentially weakening Amazon’s retail and advertising moat. That’s real. But I think it plays out slowly, Amazon will adapt through its own agents, including Project Moonraker, or partnerships that are seeking access into and monetization from the world’s largest ecommerce platform, and in an agent-first world the upside to AWS, Trainium, Graviton and Amazon’s broader AI infrastructure business could ultimately more than offset the advertising dollars at risk. Then there’s Anthropic. A recent barrage of negative headlines around slowing growth and Meta/Microsoft reducing Claude usage has spilled over into $AMZN sentiment. Again, worth taking seriously. But much of that narrative looks incomplete. Anthropic’s revenue growth remains extraordinary, its IPO appears very much alive, and its massive long term commitment to AWS remains intact. We are still early and one can make a strong argument that AWS has more to gain from an open source first AI world than it would lose from Anthropic’s and OAI’s relative weakness, if it even plays out that way. And now sharply higher diesel prices create another near term headwind to Amazon’s shipping margins. That’s real too. But either fuel prices normalize or as with past cost inflation Amazon eventually passes much of the higher cost through while continuing to drive down fulfillment costs. I don’t need the counter thesis to be wrong to own $AMZN. I just need the bull thesis to be more right.

Investor Letters

All letters

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $114B
Cestrian Capital Research 1 click

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

AMZN $2.9T
Cestrian Capital Research 3 clicks
SAP · long

Sap Se

SAP shares are down 45% since February 2025 as AI disruption fears create a long thesis on its risk-reward.

SAP $271B
Value Investors Club 2 clicks

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

SOFI $22B
WHAT ARE WE DOING? “Contrarians At The Gate” 3 clicks

Intel Q3 2026: Dead Inside

Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…

INTC $348B
Irrational Analysis 2 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 70 of 272

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

266 firms

Sectors

Ordered by how often our editor reaches for them.